Lijiang Huang - Publications

Hepatocyte OTUD1 deubiquitinates and activates ERK1/2 to promote acetaminophen-induced liver injury.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 01, 2025

Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4-Mediated Acute Hepatitis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2025

1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3.

Journal: International immunopharmacology

Published: October 20, 2025

Intestinal Epithelial-Derived USP13 Alleviates Colonic Inflammation by Suppressing GRP78-mediated Endoplasmic Reticulum Stress.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 12, 2025

Deubiquitinase OTUD6A alleviates acetaminophen-induced liver injury by targeting EZH2 to reduce cell death in hepatocytes.

Journal: Acta pharmaceutica Sinica. B

Published: October 16, 2024

Submucosal tumor-like acute purulent gastritis.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 26, 2024

Unable to exit during difficult colonoscopy examination.

Journal: Gastrointestinal endoscopy

Published: September 08, 2024

Titanium clip combined with rubber band-assisted ERCP cannulation of a hidden papilla within duodenal diverticula.

Journal: Gastrointestinal endoscopy

Published: April 09, 2024

Islet cell spheroids produced by a thermally sensitive scaffold: a new diabetes treatment.

Journal: Journal of nanobiotechnology

Published: March 25, 2024

Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes.

Journal: International immunopharmacology

Published: March 04, 2024

Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in inflammatory bowel disease by targeting TLR2.

Journal: Toxicology and applied pharmacology

Published: December 03, 2023

Toll-like receptor 2 deficiency ameliorates obesity-induced cardiomyopathy via inhibiting NF-κB signaling pathway.

Journal: International immunopharmacology

Published: November 12, 2023